• Espanol
  • Print
  • Sitemap
  • Email this Page


  • Practices
  • Professionals
  • News, Articles & Events
    • News About KPKB
    • Articles By KPKB
    • Events With KPKB
  • Media Center
  • Careers
  • About Us
Home > News, Articles & Events > Intellecual Property: Pharmaceuticals - Recent Developments

Intellecual Property: Pharmaceuticals - Recent Developments

  • Related Practices
    • Intellectual Property Law

Date: December 31, 1969

Ortho-McNeil Pharmaceutical, Inc. v. Caraco Pharmaceutical Laboratories, Ltd. (Federal Circuit, January 19, 2007)

Trial Court Correctly Set Range of Weight Ratios When Ambiguous Term ‘About’ Was Used

Plaintiff claimed infringement of patent for chemical composition of tramadol and acetaminophen. Defendant’s weight ratio between these two substances was at least 1:7.5, but plaintiff’s claim limitation was a weight ratio of “about 1:5,” which the trial court held encompassed a range of ratios between 1:3.6 and 1:7.1. The Federal Circuit upheld the trial court’s grant of summary judgment against the claim of infringement – both literal and by equivalents -- finding that the lower court correctly gauged the range of weight ratios in the term “about 1:5.” The Federal Circuit refused to extend the range any higher than 1:7.1 under the Doctrine of Equivalents. Click here for full version.


The Miami Center
201 South Biscayne Blvd
Seventeenth Floor
Miami, Florida 33131
(305) 379-9000

Peninsula Executive Center
2385 N.W. Executive Center Dr.,
Suite 300
Boca Raton, Florida 33431
(561) 443-0800
Home   | Disclaimer  |  Contact Us
© 2008 KPKB  |  Site By Firmseek